C4 Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SQUADRON CAPITAL MANAGEMENT LLC | 11/16/2026 | 9.32 M | $31.03 M | 29.43% | 7.13% |
| MORGAN STANLEY | 11/13/2026 | 8.87 M | $29.55 M | 0.06% | 6.79% |
| RA CAPITAL MANAGEMENT, L.P. | 11/16/2026 | 8.19 M | $27.29 M | 2.43% | 6.27% |
| BLACKROCK, INC. | 11/13/2026 | 8.18 M | $27.24 M | 3.59% | 6.26% |
| LYNX1 CAPITAL MANAGEMENT LP | 11/16/2026 | 7.53 M | $25.08 M | 2.79% | 5.76% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/16/2026 | 7.17 M | $23.88 M | 0.00% | 5.49% |
| CITADEL ADVISORS LLC | 11/16/2026 | 5.01 M | $16.67 M | 19.57% | 3.83% |
| JPMORGAN CHASE & CO | 11/12/2026 | 4.70 M | $14.70 M | -1.06% | 3.59% |
| GOLDMAN SACHS GROUP INC | 11/16/2026 | 4.68 M | $15.60 M | 32.64% | 3.58% |
| VANGUARD CAPITAL MANAGEMENT LLC | 11/13/2026 | 4.58 M | $15.26 M | 3.71% | 3.51% |
| BOXER CAPITAL MANAGEMENT, LLC | 11/16/2026 | 4.15 M | $13.82 M | 100.00% | 3.18% |
| TWO SIGMA INVESTMENTS, LP | 11/16/2026 | 3.75 M | $12.48 M | 7.98% | 2.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2026 | 3.45 M | $11.50 M | 13.94% | 2.64% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/16/2026 | 3.36 M | $11.18 M | -0.59% | 2.57% |
| STEMPOINT CAPITAL LP | 11/16/2026 | 3.29 M | $10.97 M | 528.93% | 2.52% |
| BANK OF AMERICA CORP /DE/ | 11/16/2026 | 2.89 M | $9.63 M | 8.82% | 2.21% |
| CANDRIAM S.C.A. | 11/03/2026 | 2.76 M | $9.23 M | 53.61% | 2.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/06/2026 | 2.70 M | $8.99 M | 7.03% | 2.07% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/13/2026 | 2.40 M | $7.98 M | 546.89% | 1.83% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/16/2026 | 2.23 M | $7.44 M | 664.79% | 1.71% |
| STATE STREET CORP | 11/12/2026 | 2.22 M | $7.39 M | 4.87% | 1.70% |
| D. E. SHAW & CO., INC. | 11/16/2026 | 2.16 M | $7.20 M | 24.19% | 1.65% |
| IKARIAN CAPITAL, LLC | 11/16/2026 | 1.93 M | $6.44 M | -20.55% | 1.48% |
| ACADIAN ASSET MANAGEMENT LLC | 11/09/2026 | 1.79 M | $5.95 M | -1.04% | 1.37% |
| DIMENSIONAL FUND ADVISORS LP | 11/04/2026 | 1.38 M | $4.61 M | 16.53% | 1.06% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/16/2026 | 1.23 M | $4.11 M | 58.08% | 0.94% |
| RENAISSANCE TECHNOLOGIES LLC | 11/12/2026 | 1.21 M | $4.03 M | 1.64% | 0.93% |
| FMR LLC | 11/10/2026 | 1.18 M | $3.92 M | 31.50% | 0.90% |
| NORTHERN TRUST CORP | 11/16/2026 | 1.16 M | $3.85 M | -0.27% | 0.89% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11/13/2026 | 1.09 M | $3.64 M | 60.89% | 0.84% |
| ATOM INVESTORS LP | 11/16/2026 | 911.53 K | $3.04 M | 150.18% | 0.70% |
| HIGHVISTA STRATEGIES LLC | 11/13/2026 | 873.28 K | $2.91 M | -35.22% | 0.67% |
| MARSHALL WACE, LLP | 11/13/2026 | 855.81 K | $2.85 M | 277.00% | 0.65% |
| AQR CAPITAL MANAGEMENT LLC | 11/16/2026 | 767.99 K | $2.56 M | 100.00% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/16/2026 | 737.00 K | $2.45 M | 184.23% | 0.56% |
| VANGUARD FIDUCIARY TRUST CO | 11/13/2026 | 721.74 K | $2.40 M | 18.48% | 0.55% |
| PANAGORA ASSET MANAGEMENT INC | 11/12/2026 | 690.69 K | $2.30 M | 160.69% | 0.53% |
| NUVEEN, LLC | 11/10/2026 | 591.83 K | $1.97 M | 22.28% | 0.45% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/16/2026 | 585.01 K | $1.95 M | -20.55% | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/16/2026 | 577.53 K | $1.92 M | 50.10% | 0.44% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/10/2026 | 546.35 K | $1.82 M | 81.67% | 0.42% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/13/2026 | 517.59 K | $1.72 M | 4.39% | 0.40% |
| SQUAREPOINT OPS LLC | 11/09/2026 | 516.55 K | $1.72 M | 202.37% | 0.40% |
| IKARIAN CAPITAL, LLC | 11/16/2026 | 500.00 K | $1.67 M | 100.00% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/16/2026 | 494.97 K | $1.65 M | -71.43% | 0.38% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/16/2026 | 451.93 K | $1.41 M | 100.00% | 0.35% |
| SQUADRON CAPITAL MANAGEMENT LLC | 11/16/2026 | 400.00 K | $1.33 M | 0.00% | 0.31% |
| WELLS FARGO & COMPANY/MN | 11/16/2026 | 396.27 K | $1.32 M | -12.47% | 0.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/16/2026 | 367.91 K | $1.23 M | 61.53% | 0.28% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/16/2026 | 340.42 K | $1.13 M | 95.68% | 0.26% |
C4 Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 185 institutional investors and hedge funds held shares of C4 Therapeutics Inc. The most heavily invested institutionals were:
Squadron Capital Management LLC: 9.32 M
MORGAN STANLEY: 8.87 M
RA CAPITAL MANAGEMENT, L.P.: 8.19 M
BlackRock, Inc.: 8.18 M
Lynx1 Capital Management LP: 7.53 M
Bain Capital Life Sciences Investors, LLC: 7.17 M
101.10% of C4 Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 143.38 M shares in the last 24 months. This purchase volume represents approximately $355.59 M in transactions.